UK evidence-led drug information
UK Drug Trends Intelligence ↗TD Consultancy ↗

Research compounds → illicit SCRAs

A history of synthetic cannabinoids

Research chemicals, rapidly changing retail products, prohibition and a persistent mismatch between branding and pharmacology.

TD ConsultancyPublished 5 August 2026Reviewed 5 August 2026Historical overview · evidence graded below
01

Laboratory compounds

Synthetic cannabinoid receptor agonists were developed through legitimate pharmacological research. Evidence note: Established.

02

Retail products

Compounds appeared in smoking mixtures sold under changing names and misleading 'herbal' branding. Evidence note: Established.

03

Generic controls

UK law increasingly used generic definitions as markets substituted new compounds. Evidence note: Established.

Why this history matters now

Products called Spice or similar names may contain different compounds and strengths. Brand continuity does not imply chemical continuity.

Myths, disputes and uncertainty

Popular drug histories often compress complex cultural, commercial and political developments into a single inventor, date or scandal. This page uses only broad claims that can be supported confidently. Where an origin story is contested or documentation is incomplete, it is not presented as settled fact.